Evidence map›Paper›PMID 38948310›Full record

ReviewJournal of pharmacopuncture2024

Hyeonjin Kim, Soohyun Jeong, Sung Wook Kim, Hyung-Jin Kim, Dae Yong Kim, Tae Han Yook, Gabsik Yang

Abstract readReview
In one paragraph

Review in Journal of pharmacopuncture, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Chemistry and Biological Activity of 11Molecules (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hyeonjin KimDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0001-5380-9610
Soohyun JeongDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0002-5274-0698
Sung Wook KimDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0001-5394-0280
Hyung-Jin KimDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0009-0006-8311-1276
Dae Yong KimDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0001-9532-809X
Tae Han YookDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0001-6379-7596
Gabsik YangDepartment of Korean Medicine, College of Korea Medicine, Woosuk University, Jeonju, Republic of Korea.ORCID https://orcid.org/0000-0002-9158-6531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the therapeutic potential of

Indexed as

anti-inflammatoryimmunomodulationIndigo Naturalisinflammatory bowel diseaseintestinal microbiotarandom clinical trial

Identifiers

PMID38948310
PMCPMC11194518

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.